FDA
approval
· 2022-10-13
FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved a supplemental application for Lithium Carbonate ER from Glenmark Pharmaceuticals, authorizing an extended-release formulation of lithium carbo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)